Begin typing your search...
India's Serum Institute to boost vaccine exports gradually, report says
The Serum Institute of India, which produces the AstraZeneca COVID-19 vaccine, will resume small exports via the global vaccine-sharing platform COVAX this month and raise it substantially by January, its head told The Telegraph.
By
migrator
migrator
New Delhi
"Our exports to COVAX will recommence again in October, initially these supplies will be small but by January 2022, once we have satisfied domestic demands – people forget that India is still a lower-middle-income country – we will see large volumes go to COVAX," Chief Executive Adar Poonawalla said.
Visit news.dtnext.in to explore our interactive epaper!
Download the DT Next app for more exciting features!
Click here for iOS
Click here for Android
Next Story
